Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity

Journal of Endocrinology

Volumn 189, Issue 2, 2006, Pages 355-363

  Krechowec, Stefan O ^a   Vickers, Mark ^b   Gertler, Arieh ^a   Breier, Bernhard H ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG MECHANISM; ENERGY METABOLISM; FEMALE; GROWTH RETARDATION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; LIPID DIET; MALE; MATERNAL NUTRITION; NONHUMAN; OBESITY; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RAT STRAIN; TREATMENT FAILURE; WEANING; WEIGHT REDUCTION;

ANIMALS; ANIMALS, NEWBORN; DIET; DIETARY FATS; DISEASE SUSCEPTIBILITY; EATING; ENERGY INTAKE; FEMALE; FETAL GROWTH RETARDATION; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INJECTIONS; LEPTIN; NUTRITION DISORDERS; OBESITY; PREGNANCY; PRENATAL NUTRITION PHYSIOLOGY; RATS; RATS, WISTAR; WEIGHT LOSS;

EID: 33646799773     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06679     Document Type: Article

References (44)

1. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R & Morley JE 2004 Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53 1253-1260.
2. Barker DJ 2004 The developmental origins of adult disease. Journal of the American College of Nutrition 23 588S-595S.
3. Brabant G, Muller G, Horn R, Anderwald C, Roden M & Nave H 2005 Hepatic leptin signaling in obesity. FASEB Journal 19 1048-1050.
4. Chopra M, Galbraith S & Darnton-Hill I 2002 A global response to a global problem: the epidemic of overnutrition. Bulletin of the World Health Organisation 80 952-958.
5. El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C & Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. Journal of Clinical Investigation 105 1827-1832.
6. Fernandez-Galaz C, Fernandez-Agullo T, Perez C, Peralta S, Arribas C, Andres A, Carrascosa JM & Ros M 2002 Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats. Diabetologia 45 997-1003.
7. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB & Flier JS 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Medicine 1 1311-1314.
8. Gluckman PD & Hanson MA 2004 Living with the past: evolution, development, and patterns of disease. Science 305 1733-1736.
9. Godfrey KM & Barker DJ 2000 Fetal nutrition and adult disease. American Journal of Clinical Nutrition 71 1344S-1352S.
10. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chair BT, Rabinowitz D, Lallone RL, Burley SK & Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 543-546.
11. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA & Friedman JM 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. PNAS 94 8878-8883.
12. Hales CN & Barker DJ 2001 The thrifty phenotype hypothesis. British Medical Bulletin 60 5-20.
13. Harris R-B, Bowen HM & Mitchell TD 2003 Leptin resistance in mice is determined by gender and duration of exposure to high-fat diet. Physiological Behaviour 78 543-555.
14. Heshka JT & Jones PJ 2001 A role for dietary fat in leptin receptor, OB-Rb, function. Life Science 69 987-1003.
15. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P et al. 1999 Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Journal of the American Medical Association 282 1568-1575.
16. Kim MS, Namkoong C, Kim HS, Jang PG, Kim Pak YM, Katakami H, Park JY & Lee KU 2004 Chronic central administration of ghrelin reverses the effects of leptin. International Journal of Obesity Related Metabolic Disorders 28 1264-1271.
17. Klein S, Coppack SW, Mohamed-Ali V & Landt M 1996 Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45 984-987.
18. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI & Friedman JM 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature 379 632-635.
19. Levin BE, Dunn-Meynell AA & Banks WA 2004 Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology 286 R143-R150.
20. Lin L, Martin R, Schaffhauser AO & York DA 2001 Acute changes in the response to peripheral leptin with alteration in the diet composition. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology 280 R504-R509.
21. Lin S, Thomas TC, Storlien LH & Huang XF 2000 Development of high fat diet-induced obesity and leptin resistance in C57B1/6J mice. International Journal of Obesity Related Metabolic Disorders 24 639-646.
22. Lollmann B, Gruninger S, Stricker-Krongrad A & Chiesi M 1997 Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochemical and Biophysical Research Communications 238 648-652.
23. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1 1155-1161.
24. Martorell R, Stein AD & Schroeder DG 2001 Early nutrition and later adiposity. Journal of Nutrition 131 874S-880S.
25. McMillen IC & Robinson JS 2005 Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiological Reviews 85 571-633.
26. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA et al. 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 903-908.
27. Monteiro CA, Moura EC, Conde WL & Popkin BM 2004 Socioeconomic status and obesity in adult populations of developing countries: a review. Bulletin ofthe World Health Organisation 82 940-946.
28. Munzberg H, Flier JS & Bjorbaek C 2004 Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 4880-4889.
29. Ozanne SE 2001 Metabolic programming in animals. British Medical Bulletin 60 143-152.
30. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T & Collins F 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269 540-543.
31. Peralta S, Carrascosa JM, Gallardo N, Ros M & Arribas C 2002 Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction. Biochemical and Biophysical Research Communications 296 425-428.
32. Popkin BM & Gordon-Larsen P 2004 The nutrition transition: worldwide obesity dynamics and their determinants. International Journal of Obesity Related Metabolic Disorders 28 (Suppl 3) S2-S9.
33. Rodgers A, Vaughan P, Prentice T, Tan-Torres Edejer T, Evans D & Lowe J 2002 The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization.
34. Schwartz MW, Seeley RJ, Campfield LA, Burn P & Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. Journal of Clinical Investigation 98 1101-1106.
35. Shimabukuro, M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB & Unger RH 1997 Direct antidiabetic effect of leptin through triglyceride depletion of tissues. PNAS 94 4637-4641.
36. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M et al. 2001 Ghrelin, an enclogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 227-232.
37. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD & Davis HR, Jr. 1997 Diet-induced obese mice develop peripheral, but not central, resistance to leptin. Journal of Clinical Investigation 99 385-390.
38. Velkoska E, Morris MJ, Burns P & Weisinger RS 2003 Leptin reduces food intake but does not alter weight regain following food deprivation in the rat. International Journal of Obesity Related Metabolic Disorders 27 48-54.
39. Vickers MH, Breier BH, Cutfield WS, Hofman PL & Gluckman PD 2000 Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. American Journal of Physiology and Endocrinological Metabolism 279 E83-E87.
40. Vickers MH, Ikenasio BA & Breier BH 2001 IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 142 3964-3973.
41. Vickers MH, Ikenasio BA & Breier BH 2002 Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment. Journal of Endocrinology 175 615-623.
42. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH & Harris M 2005 Neonatal leptin treatment reverses developmental programming. Endocrinology 146 4211-4216.
43. Zammit VA 2002 Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance. Annals of the New York Academy of Science 967 52-65.
44. Zammit VA, Lankester DJ, Brown AM & Park BS 1999 Insulin stimulates triacylglycerol secretion by perfused livers from fed rats but inhibits it in livers from fasted or insulin-deficient rats implications for the relationship between hyperinsulinaemia and hypertriglyceridaemia. European Journal of Biochemistry 263 859-864.